Showing results (1-10 of 393) with videos related to

Sort By:
Pageof 40
La Clinica Terapeutica|June 24, 2026
Bone Marrow Edema in Rheumatic Diseases: Incidence, Diagnosis, and Therapeutic Implications. A Narrative ReviewNazzarena Malavolta, Gianantonio Saviola, Sergio Rosini, et al.
Minerva Medica|June 28, 2018
Clodronate in the management of different musculoskeletal conditionsBruno Frediani, Andrea Giusti, Gerolamo Bianchi, et al.
Current Rheumatology Reviews|January 8, 2025
Clodronate: The Influence on ATP Purinergic SignalingSergio Rosini, Stefano Rosini, Gianantonio Saviola, et al.
Current Rheumatology Reviews|September 29, 2022
Mesenchymal Cells are a Promising -But Still Unsatisfying- Anti- Inflammatory Therapeutic Strategy for Osteoarthritis: A Narrative ReviewSergio Rosini, Gianantonio Saviola, Laura Comini, et al.
Minerva Medica|August 5, 2024
Adenosine triphosphate: a new player in complex regional pain syndrome type 1Sergio Rosini, Stefano Rosini, Gianantonio Saviola, et al.
Diagnostics (Basel, Switzerland)|September 27, 2025
The Warm Phase of CRPS Type-1: Is It Time to Review the Budapest Criteria?Gianantonio Saviola, Sergio Rosini, Luigi Molfetta, et al.
Current Rheumatology Reviews|October 7, 2021
Role of the Osteochondral Unit in the Pathogenesis of Osteoarthritis: Focus on the Potential Use of ClodronateLuigi Molfetta, Andrea Casabella, Sergio Rosini, et al.
Minerva Medica|June 24, 2020
Use of clodronate for painful knee prosthesis in osteoarthritis patients: a 6-month pilot studyGianantonio Saviola, Paolo Ferrari, Ernesto Niccolò, et al.
Rheumatology International|May 18, 2010
Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real lifeMaurizio Benucci, Gianantonio Saviola, Paola Baiardi, et al.
Recenti Progressi in Medicina|March 16, 2006
[Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate]Maurizio Benucci, Stefano Dolenti, Gianantonio Saviola, et al.
Pageof 40